SEC Form 4 · accession 0001437749-16-033052
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Larry D Hiebert
Officer — Executive Vice President
Period of report
May 26, 2016
Accepted (ET)
May 31, 2016 · 2:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (Right to Buy) | $11.49 | May 26, 2016 | M | 15,000 | A | Jun 26, 2016 | May 26, 2023 | Common Stock | 15,000 | 15,000 | D |
| Right to Buy Restricted Stock Unit (RSU)F2,F1 | — | May 26, 2016 | M | 5,000 | A | May 26, 2019 | — | Common Stock | 5,000 | 5,000 | D |
Explanation of responses
- F1Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.
- F2The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.